Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ · Healthcare
Vanda Pharmaceuticals Inc. annual/quarterly shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Vanda Pharmaceuticals Inc. shareholder equity for the quarter ending December 31, 2025 were 327.2M, a 39.25% decrease year-over-year.
- Vanda Pharmaceuticals Inc. shareholder equity for 2025 were 327.2M, a 39.25% decrease from 2024.
- Vanda Pharmaceuticals Inc. shareholder equity for 2024 were 538.5M, a 1.17% decrease from 2023.
- Vanda Pharmaceuticals Inc. shareholder equity for 2023 were 544.9M, a 3.36% increase from 2022.
- Vanda Pharmaceuticals Inc. shareholder equity for 2022 were 527.2M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Vanda Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $327 |
| 2024 | $539 |
| 2023 | $545 |
| 2022 | $527 |
| 2021 | $505 |
| 2020 | $453 |
| 2019 | $411 |
| 2018 | $275 |
| 2017 | $131 |
| 2016 | $131 |
| 2015 | $133 |
| 2014 | $161 |
| 2013 | $44 |
| 2012 | $10 |
| 2011 | $33 |
| Vanda Pharmaceuticals Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $327 |
| 2024-12-31 | $539 |
| 2023-12-31 | $545 |
| 2022-12-31 | $527 |
| 2021-12-31 | $505 |
| 2020-12-31 | $453 |
| 2019-12-31 | $411 |
| 2018-12-31 | $275 |
| 2017-12-31 | $131 |
| 2016-12-31 | $131 |
| 2015-12-31 | $133 |
| 2014-12-31 | $161 |
| 2013-12-31 | $44 |
| 2012-12-31 | $10 |
| 2011-12-31 | $33 |
| 2010-12-31 | $38 |
Vanda Pharmaceuticals Inc. Shareholder Equity — FAQ
Vanda Pharmaceuticals Inc. (VNDA) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VNDA's shareholder equity history?
The chart and table above show Vanda Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.